Home Monitoring During Chemoradiation

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Locally Advanced Oesophageal Cancer
Interventions
DEVICE

AMCOR

Participants will collect biometric and quality of life data for 9 or 10 weeks at home, depending on treatment schedule. Continuous step counting will be used to register physical activity. Participants will be asked to measure their blood pressure, heart rate, oxygen saturation level, pain level and temperature each morning, and weight 3 times a week. These measurements consume little time and are not harmful. Once a week they will perform a finger stick test themselves to determine creatinine concentration in the blood. In addition, patients fill in three questionnaires at four time points which will take approximately 20 minutes to complete per time point. We do not foresee reasonable risks of these diagnostic procedures for the participants.

Trial Locations (1)

9713 GZ

RECRUITING

University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Siemens Corporation, Corporate Technology

INDUSTRY

collaborator

Nova Biomedical

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT06597240 - Home Monitoring During Chemoradiation | Biotech Hunter | Biotech Hunter